NCT01154348 - Study to Assess Safety and Pharmacokinetics of Double-Blind S-707106 Alone and in Combination With Open-Label Metformin in Patients With Type 2 Diabetes Mellitus | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

December 31, 2010

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

S-707106

Tablet, taken once daily with morning meal

DRUG

Placebo

Placebo tablet, taken once daily with morning meal

DRUG

Metformin, S-707106 plus metformin

Metformin twice daily maintenance, S-707106 tablet taken once daily with morning meal with metformin dosed twice daily

DRUG

Metformin, placebo plus metformin

Metformin twice daily maintenance, placebo tablet taken once daily with morning meal with metformin twice daily

Trial Locations (1)

Dennis Ruff, MD, San Antonio